Navigation Links
FDA Warns of Unapproved and Illegal H1N1 Drug Products Purchased Over the Internet
Date:10/15/2009

the active ingredient."

Consumers may not know exactly what they are getting when buying such antiviral products on the Internet from an unfamiliar company. Patients who buy prescription drugs from Web sites operating outside the law are at increased risk of suffering life-threatening adverse events, such as side effects from inappropriately using prescription medications, dangerous drug interactions, contaminated drugs, and impure or unknown ingredients found in unapproved drugs. This may particularly be the case in the event of a public health emergency, such as an influenza outbreak, where approved treatment options would be in high demand and expensive, and where drug shortages could occur.

Drugs that are in high demand are vulnerable to counterfeiting and diversion because buyers may be desperate to stock the product, and criminals capitalize on the situation.

The FDA urges consumers to only purchase FDA-approved products from licensed pharmacies located in the United States. Consumers should contact their health care provider if they have any questions or concerns about medical products or personal protective equipment.

The two antiviral drugs approved by the FDA for treatment and prophylaxis of the 2009 H1N1 influenza virus are Tamiflu (oseltamivir phosphate) and Relenza (zanamivir).

Tamiflu and Relenza, in addition to their approved label, have Emergency Use Authorizations that describe specific authorized uses during this public health emergency.

The FDA actively monitors the Internet, and where appropriate, will purchase and analyze drug products.

Consumers can also visit FDA's Web site for tips about how to protect themselves when buying medicines online.

Media Inquiries: Christopher Kelly, 301-796-4676 '/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Concord Coalition Warns That New Entitlement Is Not a Valid Health Care Reform Offset
2. Letter Warns About Tricky Dosing With Liquid Tamiflu for Kids
3. VA Warns Veterans of Telephone Prescription Scam
4. FDA Warns Consumers Not to Use Stolen Albuterol Sulfate Inhalation Solution and Ipratropium Bromide Inhalation Solution
5. Social Security Advisory Board Warns of Consequences of Unsustainable Growth in The Cost of Health Care
6. Drug Companies Often Unprepared For REMS Evaluation, Expert Warns
7. Hissey Kientz, LLP Warns Duragesic Patch Users about Potential Health Risks of Fentanyl Overdose
8. Retirees health-care benefits at risk, study warns
9. Ohio Law Firm Warns of Birth Control Pill YAZ/Yasmin Side Effects Lawsuits
10. Ex-House Aging Committee Chief of Staff Bob Weiner Warns of Insurance Control Over Health Bill Outcome, Praises House Version, Disappointed by Senate; Weiner and Policy Analyst Jordan Osserman Offer Bills Prognosis
11. Massachusetts Warns: Bisphenol A Toxic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... CA (PRWEB) May 28, 2015 Cosmetic ... of plastic surgeons and patients alike. You can find ... breast augmentation, and body contouring. Readers can directly connect ... streamlined user experience from the ground up. , The ... is allowing the community to grow and getting it ...
(Date:5/28/2015)... 28, 2015 Today the National Resident ... for the 2015 Main Residency Match®. A record-number ... were filled when the matching algorithm was processed. ... during the Match Week Supplemental Offer and Acceptance Program® ... are pleased with the outcome of the 2015 Main ...
(Date:5/28/2015)... CA (PRWEB) May 28, 2015 The USC ... outpatient wound center management for a decade with a current ... was formed between USC and Wound Care Advantage to provide ... recognized for a drop in the rate of ... , Wound healing is a complex undertaking that can frighten ...
(Date:5/28/2015)... Bronx, NY (PRWEB) May 28, 2015 ... Urgent Care are proud to present Dr. Alicia Almendral ... will be a big part of the newly opened ... very finest in modern cosmetic treatments. , Dr. Almendral ... experienced in the latest anti-aging and cosmetic enhancement techniques. ...
(Date:5/28/2015)... 28, 2015 AMVETS National Executive Director ... Commission on Care established by Congress to examine how ... , Appointed to the commission by Mitch McConnell, majority ... one of only 15 voting members on the panel, ... Accountability Act of 2014. The goal of the commission ...
Breaking Medicine News(10 mins):Health News:New York Cosmetic Doctors Now in Cosmetic Town 2Health News:New York Cosmetic Doctors Now in Cosmetic Town 3Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 2Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 3Health News:USC Verdugo Hills Hospital Wound Care Team Provides Outstanding Healing Results 2Health News:Bella Diosa Med Spa Welcomes Botox Specialist to Yonkers Community 2Health News:AMVETS Executive Director Stewart Hickey Appointed to Congressional Commission on Care 2
... surgery, which is used to treat Parkinsons disease and ... potential to treat a variety of conditions. For example, ... cluster headaches and aggressiveness in humans, and stimulating this ... found that hypothalamic DBS performed in the treatment of ...
... the radiocarbon dating method and special proteins in the lens ... Aarhus can now establish, with relatively high precision, when a ... scientists who can use it to establish the date of ... consequences for health science research. The findings are published in ...
... preventable source of death and disability in the USA, contributing ... the health dangers, 1 in 8 American adults is ... scientists have known that most of the risk for habitual ... by genetics. This conclusion comes from the study of ...
... degree program addresses growing mental health workforce,crisis, ... the,growing mental health workforce crisis, California Institute of ... program in,Community Mental Health in fall 2008., ... Psychology with a,concentration in Community Mental Health, as ...
... A drug used to treat kidney cancer also targets a ... acute myeloid leukemia (AML), the most common and lethal form ... D. Anderson Cancer Center report in the Jan. 29 edition ... a Phase I clinical trial, the drug sorafenib reduced the ...
... Adjusted net income increases 84% to $250 million ... December 31, 2007 as,follows:, , (US$ in millions, except EPS) ... Periods ... Ended ...
Cached Medicine News:Health News:Deep brain stimulation may improve memory 2Health News:The eyes have it 2Health News:DNA (driver of nicotine addiction) 2Health News:California Institute of Integral Studies Launches Groundbreaking Community Mental Health Program 2Health News:California Institute of Integral Studies Launches Groundbreaking Community Mental Health Program 3Health News:Kidney cancer drug attacks a major type of acute myeloid leukemia 2Health News:Kidney cancer drug attacks a major type of acute myeloid leukemia 3Health News:Flextronics Announces Third Quarter Results 2Health News:Flextronics Announces Third Quarter Results 3Health News:Flextronics Announces Third Quarter Results 4Health News:Flextronics Announces Third Quarter Results 5Health News:Flextronics Announces Third Quarter Results 6Health News:Flextronics Announces Third Quarter Results 7Health News:Flextronics Announces Third Quarter Results 8Health News:Flextronics Announces Third Quarter Results 9Health News:Flextronics Announces Third Quarter Results 10Health News:Flextronics Announces Third Quarter Results 11Health News:Flextronics Announces Third Quarter Results 12Health News:Flextronics Announces Third Quarter Results 13Health News:Flextronics Announces Third Quarter Results 14Health News:Flextronics Announces Third Quarter Results 15Health News:Flextronics Announces Third Quarter Results 16Health News:Flextronics Announces Third Quarter Results 17Health News:Flextronics Announces Third Quarter Results 18Health News:Flextronics Announces Third Quarter Results 19
(Date:5/28/2015)... 2015  Eli Lilly and Company (NYSE: LLY ) ... tender offer for up to $1.6 billion aggregate principal amount ... of notes who tendered, and did not validly withdraw, their ... City time, on May 27, 2015 (the early ... are eligible to receive the total consideration. The total consideration ...
(Date:5/28/2015)... 2015 Zimmer Holdings, Inc. (NYSE and SIX: ... with buyers to divest in the United ... assets, Biomet Discovery® Elbow System assets and Cobalt™ bone ... Zimmer,s pending acquisition of Biomet, Inc. ("Biomet").  ... constructively with the Bureau of Competition Staff of the ...
(Date:5/28/2015)... , May 28, 2015 /PRNewswire/ - ESSA Pharma Inc. ... for the second quarter and three and six months ended ... Canadian dollars and in accordance with International Financial Reporting Standards ... recorded a net loss of $5.9 million ($0.35 per common ... compared to a net loss of $0.4 million ($0.03 per ...
Breaking Medicine Technology:Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 2Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 3Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 4Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 5Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 6Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5
... 4 Thoratec Corporation (Nasdaq: THOR ), a world ... and restore failing hearts, said today that revenues for the ... of nine percent over revenues of $80.8 million in the ... reflect a 14 percent increase in revenues from the company,s ...
... YORK, Nov. 4 NeoStem, Inc. (NYSE Amex: ... has been named to the Company,s Board of Directors. ... operating global biotechnology businesses. , Serving as Executive Vice ... global commercial operations of Abraxis Bioscience, a global biotechnology ...
Cached Medicine Technology:Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 2Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 3Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 4Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 5Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 6Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 7Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 8Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 9Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 10Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 11Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 12Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 13Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 14Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 15Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 16Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 17Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 18Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent 19NeoStem, Inc. Names Edward Geehr, M.D. to Board of Directors; Biotechnology Executive Brings Scientific and Business Experience in Global Operations 2NeoStem, Inc. Names Edward Geehr, M.D. to Board of Directors; Biotechnology Executive Brings Scientific and Business Experience in Global Operations 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: